Leukemia - Molecular Biology
Literature Analysis
Mouse over the terms for more detail; many indicate links which you can click for dedicated pages about the topic.
Clicking on the Gene or Topic will take you to a separate more detailed page. Sort this list by clicking on a column heading e.g. 'Gene' or 'Topic'.
Gene | Location | Aliases | Notes | Topic | Papers |
BCR | 22q11.23 | ALL, CML, PHL, BCR1, D22S11, D22S662 | -t(9;22)(p24;q11.2) BCR-JAK2 fusion -BCR and Leukaemia | 3000 | |
LMO1 | 11p15.4 | TTG1, RBTN1, RHOM1 | Translocation | -t(11;14)(p15;q11) and LMO1 in T-ALL | 3000 |
FLT3 | 13q12.2 | FLK2, STK1, CD135, FLK-2 | -FLT3 and Leukaemia | 1604 | |
PML | 15q24.1 | MYL, RNF71, PP8675, TRIM19 | Translocation | -t(15;17)(q21;q21) RARA-PML translocation in Acute Promyelocytic Leukaemia -PML and Leukaemia | 1048 |
TP53 | 17p13.1 | P53, BCC7, LFS1, TRP53 | -TP53 and Leukaemia | 838 | |
NRAS | 1p13.2 | NS6, CMNS, NCMS, ALPS4, N-ras, NRAS1 | -NRAS and Leukemia | 629 | |
JAK2 | 9p24.1 | JTK10, THCYT3 | Translocation | -JAK2 and Leukaemia -t(9;12)(p24;p13) ETV6-JAK2 fusion in lymphoid and myeloid leukemia -t(8;9)(p22;p24) PCM1-JAK2 fusion in Hematologic Malignancies -t(9;22)(p24;q11.2) BCR-JAK2 fusion | 482 |
CEBPA | 19q13.11 | CEBP, C/EBP-alpha | -CEBPA and Myeloid Leukemia | 435 | |
CD33 | 19q13.41 | p67, SIGLEC3, SIGLEC-3 | -CD33 and Myeloid Leukemia | 327 | |
MYH11 | 16p13.11 | AAT4, FAA4, SMHC, SMMHC | -MYH11 and Myeloid Leukemia | 257 | |
RUNX1T1 | 8q21.3 | CDR, ETO, MTG8, AML1T1, ZMYND2, CBFA2T1, AML1-MTG8 | -RUNX1T1 and Myeloid Leukemia | 184 | |
CSF3R | 1p34.3 | SCN7, CD114, GCSFR | -CSF3R and Myeloid Leukemia | 180 | |
GATA1 | Xp11.23 | GF1, GF-1, NFE1, XLTT, ERYF1, NF-E1, XLANP, XLTDA, GATA-1 | -GATA1 and Myeloid Leukemia | 179 | |
MECOM | 3q26.2 | EVI1, MDS1, KMT8E, PRDM3, RUSAT2, MDS1-EVI1, AML1-EVI-1 | Translocation | -t(3;12)(p13;q22) in Leukaemia -MECOM and Leukaemia | 171 |
NUP98 | 11p15.4 | ADIR2, NUP96, NUP196 | -NUP98 and Leukaemia | 159 | |
CBFB | 16q22.1 | PEBP2B | -CBFB and Myeloid Leukemia | 159 | |
HLA-A | 6p22.1 | HLAA | -HLA-A and Leukaemia | 156 | |
CD14 | 5q31.3 | -CD14 and Myeloid Leukemia | 142 | ||
PDGFRA | 4q12 | CD140A, PDGFR2, PDGFR-2 | Deletion / Translocation | -FIP1L1-PDGFRA fusion in Leukemia -PDGFRA and Leukaemia | 72 |
GALE | 1p36.11 | SDR1E1 | -GALE and Myeloid Leukemia | 122 | |
MPL | 1p34.2 | MPLV, TPOR, C-MPL, CD110, THPOR, THCYT2 | -MPL and Myeloid Leukemia | 108 | |
PTPN11 | 12q24.13 | CFC, NS1, JMML, SHP2, BPTP3, PTP2C, METCDS, PTP-1D, SH-PTP2, SH-PTP3 | -PTPN11 and Myeloid Leukemia | 94 | |
GATA2 | 3q21.3 | DCML, IMD21, NFE1B, MONOMAC | -GATA2 and Myeloid Leukemia | 76 | |
FIP1L1 | 4q12 | Rhe, FIP1, hFip1 | Deletion / Translocation | -FIP1L1-PDGFRA fusion in Leukemia | 72 |
BAALC | 8q22.3 | -BAALC and Myeloid Leukemia | 71 | ||
MLLT3 | 9p21.3 | AF9, YEATS3 | -MLLT3 and Leukaemia | 69 | |
MN1 | 22q12.1 | MGCR, MGCR1, MGCR1-PEN, dJ353E16.2 | -MN1 and Myeloid Leukemia | 59 | |
MEIS1 | 2p14 | -MEIS1 and Myeloid Leukemia | 57 | ||
TFAP2A | 6p24.3 | AP-2, BOFS, AP2TF, TFAP2, AP-2alpha | -TFAP2A and Myeloid Leukemia | 52 | |
TFAP2C | 20q13.31 | ERF1, TFAP2G, hAP-2g, AP2-GAMMA | -TFAP2C and Myeloid Leukemia | 51 | |
PRAME | 22q11.22 | MAPE, OIP4, CT130, OIP-4 | -PRAME and Leukaemia | 48 | |
HLF | 17q22 | -HLF and Leukaemia | 47 | ||
MDS1 | 3q26 | PRDM3, MDS1-EVI1 | -MDS1 and Myeloid Leukemia | 46 | |
DNMT3B | 20q11.21 | ICF, ICF1, M.HsaIIIB | -DNMT3B and Leukaemia | 43 | |
VAV1 | 19p13.3 | VAV | -VAV1 and Leukemia | 41 | |
GFI1 | 1p22.1 | SCN2, GFI-1, GFI1A, ZNF163 | -GFI1 and Leukaemia | 41 | |
DOT1L | 19p13.3 | DOT1, KMT4 | -DOT1L and Leukaemia | 41 | |
ETV6 | 12p13.2 | TEL, THC5, TEL/ABL | Translocation | -t(5;12)(q33;p13) in Chronic Myelomonocytic Leukemia -t(9;12)(p24;p13) ETV6-JAK2 fusion in lymphoid and myeloid leukemia | 33 |
KAT6A | 8p11.21 | MOZ, MRD32, MYST3, MYST-3, ZNF220, RUNXBP2, ZC2HC6A | -KAT6A and Myeloid Leukemia | 34 | |
RAG2 | 11p12 | RAG-2 | -RAG2 and Leukaemia | 34 | |
IL21R | 16p12.1 | NILR, CD360 | -IL21R and Leukaemia | 33 | |
IL2RG | Xq13.1 | P64, CIDX, IMD4, CD132, SCIDX, IL-2RG, SCIDX1 | -IL2RG and Leukaemia | 33 | |
TRB | 7q34 | TCRB, TRB@ | -TRB and T-Cell Leukemia | 33 | |
TLX1 | 10q24.31 | TCL3, HOX11 | -TLX1 and T-Cell Leukemia | 31 | |
HOXA10 | 7p15.2 | PL, HOX1, HOX1H, HOX1.8 | -HOXA10 and Myeloid Leukemia | 31 | |
PRDM16 | 1p36.32 | MEL1, KMT8F, LVNC8, PFM13, CMD1LL | -PRDM16 and Leukaemia | 31 | |
MLLT1 | 19p13.3 | ENL, LTG19, YEATS1 | Translocation | -t(11;19)(q23;p13) in Leukaemia -MLLT1 and Leukaemia | 30 |
GSTM1 | 1p13.3 | MU, H-B, GST1, GTH4, GTM1, MU-1, GSTM1-1, GSTM1a-1a, GSTM1b-1b | Germline Prognostic | -GSTM1 Polymorphisms and Susceptibility to Leukemia | 28 |
TLX3 | 5q35.1 | RNX, HOX11L2 | -TLX3 and T-Cell Leukemia | 27 | |
CD36 | 7q21.11 | FAT, GP4, GP3B, GPIV, CHDS7, PASIV, SCARB3, BDPLT10 | -CD36 and Myeloid Leukemia | 27 | |
NSD1 | 5q35.3 | STO, KMT3B, SOTOS, ARA267, SOTOS1 | -NSD1 and Myeloid Leukemia | 24 | |
FES | 15q26.1 | FPS | -FES and Myeloid Leukemia | 24 | |
HOXD13 | 2q31.1 | BDE, SPD, BDSD, HOX4I | -HOXD13 and Leukaemia | 23 | |
G6PD | Xq28 | G6PD1 | -G6PD and Myeloid Leukemia | 22 | |
ETS2 | 21q22.2 | ETS2IT1 | -ETS2 and Leukaemia | 22 | |
SALL4 | 20q13.2 | DRRS, HSAL4, ZNF797 | -SALL4 and Leukaemia | 21 | |
HOXA5 | 7p15.2 | HOX1, HOX1C, HOX1.3 | -HOXA5 and Leukaemia | 21 | |
PBX3 | 9q33.3 | -PBX3 and Leukaemia | 21 | ||
TCL1A | 14q32.13 | TCL1 | -TCL1A and T-Cell Leukemia | 21 | |
PCM1 | 8p22 | PTC4, RET/PCM-1 | Translocation | -PCM1 and Myeloid Leukemia -t(8;9)(p22;p24) PCM1-JAK2 fusion in Hematologic Malignancies | 10 |
CSF1R | 5q32 | FMS, CSFR, FIM2, HDLS, C-FMS, CD115, CSF-1R, M-CSF-R | -CSF1R and Myeloid Leukemia | 18 | |
MRTFA | 22q13.1-q13.2 | MAL, MKL, BSAC, MKL1, MRTF-A | Translocation | -t(1;22)(p13;q13) in Acute Megakaryocytic Leukemia -MKL1 and Myeloid Leukemia | 18 |
MLF1 | 3q25.32 | -MLF1 and Myeloid Leukemia | 18 | ||
TET1 | 10q21.3 | LCX, CXXC6, bA119F7.1 | -TET1 mutations in Leukemia | 18 | |
MYB | 6q23.3 | efg, Cmyb, c-myb, c-myb_CDS | -Genes, myb and Myeloid Leukemia | 17 | |
CBFA2T3 | 16q24.3 | ETO2, MTG16, MTGR2, ZMYND4, RUNX1T3 | -CBFA2T3 and Leukaemia | 17 | |
BCL2A1 | 15q25.1 | GRS, ACC1, ACC2, BFL1, ACC-1, ACC-2, HBPA1, BCL2L5 | -BCL2A1 and Leukemia | 15 | |
MSI2 | 17q22 | MSI2H | -MSI2 and Leukaemia | 15 | |
BCL11B | 14q32.2 | ATL1, RIT1, CTIP2, IMD49, CTIP-2, ZNF856B, ATL1-beta, ATL1-alpha, ATL1-delta, ATL1-gamma, hRIT1-alpha | -BCL11B and T-Cell Leukemia | 15 | |
HCK | 20q11.21 | JTK9, p59Hck, p61Hck | -HCK and Leukaemia | 15 | |
HOXA7 | 7p15.2 | ANTP, HOX1, HOX1A, HOX1.1 | -HOXA7 and Myeloid Leukemia | 15 | |
WT1-AS | 11p13 | WIT1, WIT-1, WT1AS, WT1-AS1 | -WT1-AS and Leukaemia | 14 | |
HLA-DPB1 | 6p21.32 | DPB1, HLA-DP, HLA-DPB, HLA-DP1B | -HLA-DPB1 and Leukaemia | 14 | |
HOXB4 | 17q21.32 | HOX2, HOX2F, HOX-2.6 | -HOXB4 and Myeloid Leukemia | 13 | |
BOLL | 2q33 | BOULE | -BOLL and Myeloid Leukemia | 12 | |
MLLT6 | 17q12 | AF17 | -MLLT6 and Leukaemia | 12 | |
DDX10 | 11q22.3 | HRH-J8 | -DDX10 and Myeloid Leukemia | 12 | |
STAM | 10p12.33 | STAM1, STAM-1 | -STAM and Myeloid Leukemia | 12 | |
MNX1 | 7q36.3 | HB9, HLXB9, SCRA1, HOXHB9 | -MNX1 and Leukaemia | 12 | |
ID2 | 2p25 | GIG8, ID2A, ID2H, bHLHb26 | -ID2 in Leukemia & Lymphoma | 11 | |
MTCP1 | Xq28 | p8MTCP1, P13MTCP1 | -MTCP1 and T-Cell Leukemia | 11 | |
SEPTIN6 | Xq24 | SEP2, SEPT2, SEPT6 | -SEPT6 and Leukaemia | 11 | |
ZNF384 | 12p13.31 | NP, CIZ, NMP4, CAGH1, ERDA2, TNRC1, CAGH1A | -ZNF384 and Leukaemia | 11 | |
CD3D | 11q23.3 | T3D, IMD19, CD3-DELTA | -CD3D and Leukaemia | 11 | |
RPN1 | 3q21.3 | OST1, RBPH1 | -RPN1 and Myeloid Leukemia | 10 | |
CD52 | 1p36.11 | HE5, CDW52, EDDM5 | -CD52 and T-Cell Leukemia | 10 | |
ITGAM | 16p11.2 | CR3A, MO1A, CD11B, MAC-1, MAC1A, SLEB6 | -ITGAM and Myeloid Leukemia | 10 | |
RAP1GDS1 | 4q23 | GDS1, SmgGDS | -RAP1GDS1 and Leukaemia | 10 | |
THY1 | 11q23.3 | CD90, CDw90 | -THY1 and Leukaemia | 9 | |
SUV39H1 | Xp11.23 | MG44, KMT1A, SUV39H, H3-K9-HMTase 1 | -SUV39H1 and Leukaemia | 9 | |
HOXB3 | 17q21.32 | HOX2, HOX2G, Hox-2.7 | -HOXB3 and Myeloid Leukemia | 9 | |
ARHGAP26 | 5q31.3 | GRAF, GRAF1, OPHN1L, OPHN1L1 | -ARHGAP26 and Myeloid Leukemia | 8 | |
SETD2 | 3p21.31 | LLS, HYPB, SET2, HIF-1, HIP-1, KMT3A, HBP231, HSPC069, p231HBP | -SETD2 and Leukaemia | 8 | |
HOXA4 | 7p15.2 | HOX1, HOX1D | -HOXA4 and Myeloid Leukemia | 8 | |
DLX4 | 17q21.33 | BP1, DLX7, DLX8, DLX9, OFC15 | -DLX4 and Leukaemia | 8 | |
HOXA11 | 7p15.2 | HOX1, HOX1I, RUSAT1 | -HOXA11 and Myeloid Leukemia | 7 | |
MIR34A | 1p36.22 | mir-34, MIRN34A, mir-34a, miRNA34A | -MIR34A and Leukaemia | 7 | |
HOXA13 | 7p15.2 | HOX1, HOX1J | -HOXA13 and Myeloid Leukemia | 7 | |
RAG1 | 11p12 | RAG-1, RNF74 | -RAG1 and T-Cell Leukemia | 7 | |
SBDS | 7q11.21 | SDS, SWDS, CGI-97 | -SBDS and Leukaemia | 7 | |
AFF4 | 5q31.1 | MCEF, CHOPS, AF5Q31 | -AFF4 and Leukaemia | 7 | |
TCF12 | 15q21.3 | HEB, CRS3, HTF4, TCF-12, bHLHb20, HsT17266 | -TCF12 and Leukaemia | 6 | |
MEF2C | 5q14.3 | DEL5q14.3, C5DELq14.3 | -MEF2C and Myeloid Leukemia | 6 | |
FGFR1OP | 6q27 | FOP | -FGFR1OP and Myeloid Leukemia | 6 | |
AKAP12 | 6q25.1 | SSeCKS, AKAP250 | -AKAP12 and Myeloid Leukemia | 6 | |
HOXC13 | 12q13.13 | HOX3, ECTD9, HOX3G | -HOXC13 and Myeloid Leukemia | 6 | |
POU2AF1 | 11q23.1 | BOB1, OBF1, OCAB, OBF-1 | Translocation | -t(3;11)(q27;q23) in B-Cell Leukaemia -POU2AF1 and Leukaemia | 5 |
TJP1 | 15q13.1 | ZO-1 | -TJP1 and Leukaemia | 6 | |
ELF4 | Xq26.1 | MEF, ELFR | -ELF4 and Myeloid Leukemia | 6 | |
CD58 | 1p13.1 | ag3, LFA3, LFA-3 | -CD58 and Myeloid Leukemia | 6 | |
CD48 | 1q23.3 | BCM1, BLAST, hCD48, mCD48, BLAST1, SLAMF2, MEM-102 | -CD48 and Leukaemia | 5 | |
MARS | 12q13.3 | MRS, ILLD, CMT2U, ILFS2, METRS, MTRNS, SPG70 | -MARS and Myeloid Leukemia | 5 | |
PDCD5 | 19q13.11 | TFAR19 | -PDCD5 and Leukaemia | 5 | |
PSIP1 | 9p22.3 | p52, p75, PAIP, DFS70, LEDGF, PSIP2 | -PSIP1 and Leukaemia | 5 | |
XRCC5 | 2q35 | KU80, KUB2, Ku86, NFIV, KARP1, KARP-1 | -XRCC5 and Myeloid Leukemia | 5 | |
SH3GL1 | 19p13.3 | EEN, CNSA1, SH3P8, SH3D2B | -SH3GL1 and Leukaemia | 5 | |
ELL | 19p13.11 | MEN, ELL1, PPP1R68, C19orf17 | -ELL and Childhood Leukaemia | 5 | |
NUMA1 | 11q13.4 | NUMA, NMP-22 | -NUMA1 and Myeloid Leukemia | 5 | |
LRRC3B | 3p24.1 | LRP15 | -LRRC3B and Leukaemia | 5 | |
XRCC6 | 22q13.2 | ML8, KU70, TLAA, CTC75, CTCBF, G22P1 | -XRCC6 and Myeloid Leukemia | 4 | |
GRASP | 12q13.13 | TAMALIN | -GRASP and Leukaemia | 4 | |
SLAMF1 | 1q23.3 | SLAM, CD150, CDw150 | -SLAMF1 and Leukaemia | 4 | |
CHAT | 10q11.23 | CMS6, CMS1A, CMS1A2, CHOACTASE | -CHAT and Myeloid Leukemia | 4 | |
FLT4 | 5q35.3 | PCL, FLT-4, FLT41, LMPH1A, VEGFR3, VEGFR-3 | -FLT4 and Leukaemia | 4 | |
DOK2 | 8p21.3 | p56DOK, p56dok-2 | -DOK2 and Leukaemia | 4 | |
GAS7 | 17p13.1 | -GAS7 and Leukaemia | 4 | ||
DDIT4 | 10q22.1 | Dig2, REDD1, REDD-1 | -DDIT4 and Myeloid Leukemia | 3 | |
PCDH10 | 4q28.3 | PCDH19, OL-PCDH | -PCDH10 and Leukaemia | 3 | |
NSD3 | 8p11.23 | KMT3F, KMT3G, WHISTLE, WHSC1L1, pp14328 | -WHSC1L1 and Myeloid Leukemia | 3 | |
ABI2 | 2q33 | ABI-2, ABI2B, AIP-1, AblBP3, argBP1, SSH3BP2, argBPIA, argBPIB | -ABI2 and Leukaemia | 3 | |
SLC19A2 | 1q24.2 | TC1, THT1, TRMA, THMD1, THTR1 | -SLC19A2 and T-Cell Leukemia | 3 | |
CHIC2 | 4q12 | BTL | -CHIC2 and Myeloid Leukemia | 3 | |
CASP2 | 7q34 | ICH1, NEDD2, CASP-2, NEDD-2, PPP1R57 | -CASP2 and Leukaemia | 3 | |
PRRX1 | 1q24.2 | PMX1, PRX1, AGOTC, PHOX1, PRX-1 | -PRRX1 and Leukaemia | 3 | |
KNL1 | 15q15.1 | D40, CT29, Spc7, CASC5, MCPH4, hKNL-1, AF15Q14, PPP1R55, hSpc105 | -CASC5 and Leukaemia | 2 | |
DACH1 | 13q21.33 | DACH | -DACH1 and Myeloid Leukemia | 2 | |
ITGB2 | 21q22.3 | LAD, CD18, MF17, MFI7, LCAMB, LFA-1, MAC-1 | -ITGB2 and Myeloid Leukemia | 2 | |
PNN | 14q21.1 | DRS, DRSP, SDK3, memA | -PNN and Leukaemia | 2 | |
KMT2A | 11q23.3 | HRX, MLL, MLL1, TRX1, ALL-1, CXXC7, HTRX1, MLL1A, WDSTS | Translocation | -t(11;19)(q23;p13) in Leukaemia -t(10;11)(p11.2;q23) ABI1-MLL translocation in Leukemia | 2 |
ABI1 | 10p12.1 | E3B1, ABI-1, ABLBP4, NAP1BP, SSH3BP, SSH3BP1 | Translocation | -t(10;11)(p11.2;q23) ABI1-MLL translocation in Leukemia | 2 |
PRTN3 | 19p13.3 | MBN, MBT, NP4, P29, PR3, ACPA, AGP7, NP-4, PR-3, CANCA, C-ANCA | -PRTN3 and Myeloid Leukemia | 2 | |
ACSL6 | 5q31.1 | ACS2, FACL6, LACS2, LACS5, LACS 6 | -ACSL6 and Myeloid Leukemia | 2 | |
IFNA17 | 9p21.3 | IFNA, INFA, LEIF2C1, IFN-alphaI | -IFNA17 and Leukaemia | 1 | |
TCL6 | 14q32.13 | TNG1, TNG2 | -TCL6 and T-Cell Leukemia | 1 | |
PDCD2 | 6q27 | RP8, ZMYND7 | -PDCD2 and Leukaemia | 1 | |
PDGFRB | 5q32 | IMF1, KOGS, IBGC4, JTK12, PDGFR, PENTT, CD140B, PDGFR1, PDGFR-1 | Translocation | -t(5;12)(q33;p13) in Chronic Myelomonocytic Leukemia | 1 |
HERPUD1 | 16q13 | SUP, HERP, Mif1 | -HERPUD1 and Leukaemia | 1 | |
MAS1 | 6q25.3 | MAS, MGRA | -MAS1 and Leukaemia | 1 | |
MIR1256 | 1p36.12 | MIRN1256, hsa-mir-1256 | -MIRN1256 microRNA, human and Leukaemia | 1 | |
FCGR2B | 1q23.3 | CD32, FCG2, CD32B, FCGR2, IGFR2, FCGR2C, FcRII-c | -FCGR2B and Myeloid Leukemia | 1 | |
IFNA2 | 9p21.3 | IFNA, INFA2, IFNA2B, IFN-alphaA | -IFNA2 and Leukaemia | 1 | |
BCL5 | 17q22 | -BCL5 and Leukaemia | 1 | ||
CHCHD7 | 8q12.1 | COX23 | -CHCHD7 and Myeloid Leukemia | 1 | |
BCL6 | 3q27.3 | BCL5, LAZ3, BCL6A, ZNF51, ZBTB27 | Translocation | -t(3;11)(q27;q23) in B-Cell Leukaemia | 1 |
ITGAL | 16p11.2 | CD11A, LFA-1, LFA1A | -ITGAL and Myeloid Leukemia | ||
TFAP2B | 6p12.3 | PDA2, AP-2B, AP2-B | -TFAP2B and Myeloid Leukemia | ||
ERG | 21q22.2 | p55, erg-3 | Translocation | -t(16;21)(p11;q22) in Leukemia (ANLL) | |
FUS | 16p11.2 | TLS, ALS6, ETM4, FUS1, POMP75, HNRNPP2 | Translocation | -t(16;21)(p11;q22) in Leukemia (ANLL) | |
RBM15 | 1p13.3 | OTT, OTT1, SPEN | Translocation | -t(1;22)(p13;q13) in Acute Megakaryocytic Leukemia | |
RUNX1 | 21q22.12 | AML1, CBFA2, EVI-1, AMLCR1, PEBP2aB, CBF2alpha, AML1-EVI-1, PEBP2alpha | Translocation | -t(3;12)(p13;q22) in Leukaemia | |
NPM1 | 5q35.1 | B23, NPM | Translocation | -t(5;17)(q32;q11) RARA-NPM translocations in Acute Promyelocytic Leukemia | |
RARA | 17q21.2 | RAR, NR1B1 | Translocation | -t(5;17)(q32;q11) RARA-NPM translocations in Acute Promyelocytic Leukemia -t(15;17)(q21;q21) RARA-PML translocation in Acute Promyelocytic Leukaemia |
Note: list is not exhaustive. Number of papers are based on searches of PubMed (click on topic title for arbitrary criteria used).
Disclaimer: This site is for educational purposes only; it can not be used in diagnosis or treatment.
Cite this page: Cotterill SJ. Leukemia - Molecular Biology, Cancer Genetics Web: http://www.cancer-genetics.org/X1201.htm Accessed:
This page in Cancer Genetics Web by Simon Cotterill is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Note: content of abstracts copyright of respective publishers - seek permission where appropriate.
[Home] Page last revised: 29 August, 2019 Cancer Genetics Web, Established 1999